Schisandrin a Regulates the Nrf2 Signaling Pathway and Inhibits NLRP3 Inflammasome Activation To Interfere With Pyroptosis in a Mouse Model of COPD

Researchers studied the pharmacological effect of Schisandrin A (SchA) on airway inflammation induced by cigarette smoke and explored the therapeutic mechanism of SchA in COPD model mice.